Sidawy M K, Stoler M H, Frable W J, Frost A R, Masood S, Miller T R, Silverberg S G, Sneige N, Wang H H
Department of Pathology, The George Washington University Medical Center, Washington, DC 20037, USA.
Diagn Cytopathol. 1998 Feb;18(2):150-65. doi: 10.1002/(sici)1097-0339(199802)18:2<150::aid-dc12>3.0.co;2-k.
This study evaluates the applicability of the published cytologic criteria in the categorization of proliferative breast lesions by assessing the diagnostic accuracy and interobserver reproducibility of a panel of experts. Twelve breast fine-needle aspiration (FNA) specimens of biopsy-proven nonproliferative breast lesion (NPL) (1 case), proliferative lesions without atypia (PL) (7 cases), proliferative lesion with atypia (PLA) (1 case), and low-nuclear grade ductal carcinoma in situ (DCIS) (3 cases) were selected. Six FNAs were Papanicolaou (PAP) and 6 were Diff-Quik-stained (DQ). Six expert cytopathologists classified the smears using a summary of published criteria as a guideline. All 6 participants rendered the same cytologic diagnosis in 2/12 (16%) cases. The agreement among the 6 raters was low (Kappa = 0.35). Cytohistologic correlation was achieved in 26/72 (36%) FNA diagnoses. The correlation of the PAP-stained cases was better than the DQ: 17/36 (47%) PAP and 9/36 (25%) DQ correlated. Improving the correlation was achieved by amalgamation of NPL and PL into "low risk" and PLA and DCIS into "high risk" categories: 47/72 (65%) FNA diagnoses then correlated with histology [29/36 (81%) PAP and 18/36 (50%) DQ]. We conclude that the cytologic criteria of proliferative breast lesions need to be further defined and assessed. Consideration should be given to minimizing the number of diagnostic categories and adopting a terminology that has a direct effect on patient management.
本研究通过评估一组专家的诊断准确性和观察者间的可重复性,来评价已发表的细胞学标准在增殖性乳腺病变分类中的适用性。选取了12例经活检证实的非增殖性乳腺病变(NPL)(1例)、无异型性的增殖性病变(PL)(7例)、有异型性的增殖性病变(PLA)(1例)和低核级导管原位癌(DCIS)(3例)的乳腺细针穿刺(FNA)标本。6例FNA采用巴氏染色(PAP),6例采用Diff-Quik染色(DQ)。6名专家级细胞病理学家以已发表标准的总结为指导对涂片进行分类。6名参与者在2/12(16%)的病例中做出了相同的细胞学诊断。6名评分者之间的一致性较低(kappa = 0.35)。72例FNA诊断中有26/72(36%)实现了细胞组织学相关性。PAP染色病例的相关性优于DQ染色病例:17/36(47%)的PAP染色病例和9/36(25%)的DQ染色病例具有相关性。通过将NPL和PL合并为“低风险”类别,将PLA和DCIS合并为“高风险”类别,提高了相关性:此时72例FNA诊断中有47/72(65%)与组织学相关[29/36(81%)的PAP染色病例和18/36(50%)的DQ染色病例]。我们得出结论,增殖性乳腺病变的细胞学标准需要进一步界定和评估。应考虑尽量减少诊断类别数量,并采用对患者管理有直接影响的术语。